Clinical Science Development ▲ Sign in to save

• ▲ Irmgard Boesl

  Grünenthal Group (Germany) Medicine
  217

  citations

  6

  h-index

  4

  Aachen papers

1 result

• IMI2-PainCare-BioPain-RCT2 protocol: a randomized, double-blind, placebo-controlled, crossover, multicenter trial in healthy subjects to investigate the effects of lacosamide, pregabalin, and tapentadol on biomarkers of pain processing observed by non-invasive neurophysiological measurements of human spinal cord and brainstem activity

  2022 Trials article Medicine Pain Mechanisms and Treatments Open access

  10

  citations
• IMI2-PainCare-BioPain-RCT3: a randomized, double-blind, placebo-controlled, crossover, multi-center trial in healthy subjects to investigate the effects of lacosamide, pregabalin, and tapentadol on biomarkers of pain processing observed by electroencephalography (EEG)

  2021 Trials article Medicine Pain Mechanisms and Treatments Open access

  6

  citations
• IMI2-PainCare-BioPain-RCT1: study protocol for a randomized, double-blind, placebo-controlled, crossover, multi-center trial in healthy subjects to investigate the effects of lacosamide, pregabalin, and tapentadol on biomarkers of pain processing observed by peripheral nerve excitability testing (NET)

  2022 Trials article Medicine Pain Mechanisms and Treatments Open access

  6

  citations

3 results